A new model published online November 27 in the Journal of the National Cancer Institute (JNCI) more accurately estimates the risk of invasive breast cancer for African American women than the current NCI Breast Cancer Risk Assessment Tool ¹.

The NCI tool is widely used for determining both risk for individual women and enrollment eligibility for clinical trials of breast cancer prevention agents, but was developed using data collected primarily from white women.  Read more ²  

NCI has always placed a considerable premium on communication and education - a philosophy that grew in prominence following the passage of the National Cancer Act ³, which directed NCI to develop methods for ensuring important research findings were disseminated to researchers and to the public.

By reaching out to the public, researchers, policy makers, nonprofit organizations, and advocates, NCI can have a more robust conversation about our priorities, accomplishments, and challenges. We do it through state-of-the-science symposia, our award-winning Web site, the NCI Cancer Information Service, numerous publications, advocacy teleconferences, science writers' seminars, and much more.  Read more ⁴  

The NCI Cancer Bulletin is produced by the National Cancer Institute (NCI). NCI, which was established in 1937, leads the national effort to eliminate the suffering and death due to cancer. Through basic, clinical, and population-based biomedical research and training, NCI conducts and supports research that will lead to a future in which we can identify the environmental and genetic causes of cancer, prevent cancer before it starts, identify cancers that do develop at the earliest stage, eliminate cancers through innovative treatment interventions, and biologically control those cancers that we cannot eliminate so they become manageable, chronic diseases. For more information on cancer, call 1-800-4-CANCER or visit http://www.cancer.gov. NCI Cancer Bulletin staff can be reached at ncicancerbulletin@mail.nih.gov.